Home/ News/ Binding Site welcomes new Vice President and General Manager, Stephen Harding, PhD

Binding Site welcomes new Vice President and General Manager

Binding Site is pleased to announce the appointment of Stephen Harding, PhD, as Vice President and General Manager, effective October 1, 2025.

With a career spanning more than 23 years in diagnostics and life sciences, Ste has been an integral part of the Binding Site’s journey from its earliest days. His contributions include the development of Freelite® Assays, the launch of the Optilite® Analyser, the Binding Site’s collaboration in the groundbreaking iStopMM screening study, and most recently, the successful introduction of the EXENT® System. He is widely recognized for pioneering innovations that advance impactful diagnostics and for building global partnerships across the industry.

Looking ahead, Ste is determined to continue pushing the boundaries of specialty diagnostics to make a meaningful difference for patients and the wider scientific community:

 

“Together, we’ll keep advancing innovation in protein diagnostics and delivering impact where it matters most. I’m looking forward to working alongside our exceptional team as we write the next chapter of the Binding Site, part of Thermo Fisher Scientific.”
Image of Stephen Harding PhD
Return to news homepage